STANDIGM

Standigm is a workflow AI-driven drug discovery company. Standigm has proprietary AI platforms encompassing novel target identification to lead generation to generate commercially valuable drug pipelines. Founded in 2015, the company has established an early-stage drug discovery workflow AI to generate First-in-Class lead compounds within seven months. Pursuing full-stack, AI-driven industrializing drug discovery, Standigm has achieved the automation of molecular design workflow through DarkMolFactory™, and the automation effort has been expanding to the whole drug discovery process on the basis of Standigm AI platforms, including Standigm ASK™ for target discovery, Standigm BEST™ for lead design, and Standigm Insight™ for drug repurposing.

#SimilarOrganizations #People #Financial #Event #Website #More

STANDIGM

Social Links:

Facebook

Linkedin

Industry:

Artificial Intelligence Biotechnology Health Care Machine Learning Pharmaceutical

Founded:

2015-05-04

Address:

Seoul, Seoul-t'ukpyolsi, South Korea

Country:

South Korea

Website Url:

http://www.standigm.com

Total Employee:

101+

Status:

Active

Contact:

82-2-501-8118

Email Addresses:

[email protected]

Total Funding:

71.24 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Apache

Similar Organizations

insilico-medicine-logo

Insilico Medicine

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.

menten-ai-logo

Menten AI

Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.

visit-logo

Visit

AI driven chatbot to provide health advice within minutes.

Current Employees Featured

so-jeong-yun_image

So Jeong Yun
So Jeong Yun Chief Research Officer, Co-founder @ Standigm
Chief Research Officer, Co-founder

jinhan-kim_image

Jinhan Kim
Jinhan Kim CEO, Co-founder @ Standigm
CEO, Co-founder
2015-05-01

hee-jung-koo_image

Hee Jung Koo
Hee Jung Koo Senior Scientist/ Head of UK Office @ Standigm
Senior Scientist/ Head of UK Office

sang-ok-song_image

Sang Ok Song
Sang Ok Song COO, Co-founder @ Standigm
COO, Co-founder
2015-05-01

carl-foster_image

Carl Foster
Carl Foster Chief Business Officer @ Standigm
Chief Business Officer
2022-08-01

Founder

jinhan-kim_image

Jinhan Kim

sang-ok-song_image

Sang Ok Song

so-jeong-yun_image

So Jeong Yun

Investors List

pavilion-capital_image

Pavilion Capital

Pavilion Capital investment in Series D - Standigm

sk-global-chemical_image

SK Global Chemical

SK Global Chemical investment in Corporate Round - Standigm

kakao-ventures_image

Kakao Ventures

Kakao Ventures investment in Series C - Standigm

kdb-bank_image

KDB Bank

KDB Bank investment in Series C - Standigm

atinum-investment_image

Atinum Investment

Atinum Investment investment in Series C - Standigm

sks-pe_image

SKS PE

SKS PE investment in Series C - Standigm

wonik-investment-partners_image

WONIK Investment Partners

WONIK Investment Partners investment in Series C - Standigm

asset-one-f59c_image

Asset One

Asset One investment in Series C - Standigm

dsc-investment_image

DSC Investment

DSC Investment investment in Series C - Standigm

intervest-co_image

InterVest Co.

InterVest Co. investment in Series C - Standigm

Newest Events participated

Participated in BIO-Europe 2017 | November 6–8 in Berlin, Germany on 2017-11-06 as speaker

Key Employee Changes

Date	New article
2022-08-18	Standigm names Carl Foster chief business officer to expand strategic partnerships for AI drug discovery

Official Site Inspections

http://www.standigm.com Semrush global rank: 2.42 M Semrush visits lastest month: 7.44 K

Host Informations
Whois Informations

Loading ...

More informations about "Standigm" on Search Engine